Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 229,301 shares at $70.33 ($16.3M) on 2016-04-07, disclosed to the SEC on 2016-04-11.
Open-market sale of $16.3M ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.33 | 102,760 | $7.2M | 44.3% |
| 2 | $71.44 | 99,981 | $7.1M | 43.8% |
| 3 | $72.15 | 13,000 | $938K | 5.8% |
| 4 | $73.29 | 2,272 | $167K | 1.0% |
| 5 | $74.13 | 200 | $15K | 0.1% |
| 6 | $75.57 | 6,820 |
| $515K |
| 3.2% |
| 7 | $70.05 | 3,868 | $271K | 1.7% |
| 8 | $71.40 | 400 | $29K | 0.2% |
| Total | $71.10 avg | 229,301 | $16.3M | 100% |
| Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |
| EDGE | BUY | 2015-10-08 | $5.0M | — | Filing → |